Expression of ESRP2 in CRC compared to corresponding resection margins was found to be increased in 30 patients (61.2%), similar in eight patients (16.3%) and reduced in 11 patients (22.5%). The gene discussed is ESRP2; the disease is colorectal carcinoma.